181 related articles for article (PubMed ID: 23426901)
21. A functional interaction between ATF7 and TAF12 that is modulated by TAF4.
Hamard PJ; Dalbies-Tran R; Hauss C; Davidson I; Kedinger C; Chatton B
Oncogene; 2005 May; 24(21):3472-83. PubMed ID: 15735663
[TBL] [Abstract][Full Text] [Related]
22. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
23. Cell biology of Paget's disease.
Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
[TBL] [Abstract][Full Text] [Related]
24. Insights into the pathogenesis of Paget's disease.
Roodman GD
Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
[TBL] [Abstract][Full Text] [Related]
26. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
[TBL] [Abstract][Full Text] [Related]
27. Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.
Garcia-Palacios V; Chung HY; Choi SJ; Sarmasik A; Kurihara N; Lee JW; Galson DL; Collins R; Roodman GD
Bone; 2007 Feb; 40(2):316-22. PubMed ID: 16996813
[TBL] [Abstract][Full Text] [Related]
28. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
29. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
Rao H; Lu G; Kajiya H; Garcia-Palacios V; Kurihara N; Anderson J; Patrene K; Sheppard D; Blair HC; Windle JJ; Choi SJ; Roodman GD
J Bone Miner Res; 2006 Oct; 21(10):1657-65. PubMed ID: 16995821
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
31. MKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.
Griffin AC; Kern MJ; Kirkwood KL
Mol Endocrinol; 2012 Oct; 26(10):1682-93. PubMed ID: 22899855
[TBL] [Abstract][Full Text] [Related]
32. Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-β1 (SIRPβ1) to enhance osteoclast differentiation in Paget's disease of bone.
Sundaram K; Sambandam Y; Shanmugarajan S; Rao DS; Reddy SV
Bone Rep; 2017 Dec; 7():26-32. PubMed ID: 28840181
[TBL] [Abstract][Full Text] [Related]
33. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3.
Meyer MB; Goetsch PD; Pike JW
J Biol Chem; 2010 May; 285(20):15599-15610. PubMed ID: 20236932
[TBL] [Abstract][Full Text] [Related]
34. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
[TBL] [Abstract][Full Text] [Related]
35. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.
Sundaram K; Shanmugarajan S; Rao DS; Reddy SV
Endocrinology; 2011 Nov; 152(11):4180-9. PubMed ID: 21878516
[TBL] [Abstract][Full Text] [Related]
36. Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen.
Hentunen TA; Jackson SH; Chung H; Reddy SV; Lorenzo J; Choi SJ; Roodman GD
Endocrinology; 1999 Jul; 140(7):2954-61. PubMed ID: 10385386
[TBL] [Abstract][Full Text] [Related]
37. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.
Dwivedi PP; Omdahl JL; Kola I; Hume DA; May BK
J Biol Chem; 2000 Jan; 275(1):47-55. PubMed ID: 10617584
[TBL] [Abstract][Full Text] [Related]
38. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
Messerlian S; Gao X; St-Arnaud R
J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
[TBL] [Abstract][Full Text] [Related]
39. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
Oba Y; Chung HY; Choi SJ; Roodman GD
J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
[TBL] [Abstract][Full Text] [Related]
40. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
